These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33684684)

  • 41. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
    Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
    Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
    Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
    Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
    Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
    J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Family of Rhodium Complexes with Selective Toxicity toward Mismatch Repair-Deficient Cancers.
    Boyle KM; Barton JK
    J Am Chem Soc; 2018 Apr; 140(16):5612-5624. PubMed ID: 29620877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents.
    Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y
    Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
    Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
    J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significant enhancement of anticancer effect of iridium (III) complexes encapsulated in liposomes.
    Yang J; Zhu X; Kong D; Wang Y; Yang Y; Liu Y; Yin H
    J Inorg Biochem; 2024 Dec; 261():112706. PubMed ID: 39197384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity.
    Parveen S; Hanif M; Leung E; Tong KKH; Yang A; Astin J; De Zoysa GH; Steel TR; Goodman D; Movassaghi S; Söhnel T; Sarojini V; Jamieson SMF; Hartinger CG
    Chem Commun (Camb); 2019 Oct; 55(80):12016-12019. PubMed ID: 31498360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity.
    He SF; Pan NL; Chen BB; Liao JX; Huang MY; Qiu HJ; Jiang DC; Wang JJ; Chen JX; Sun J
    J Biol Inorg Chem; 2020 Dec; 25(8):1107-1116. PubMed ID: 33079244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
    Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
    J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
    Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
    Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
    Yan C; Zhang J; Liang T; Li Q
    Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression.
    Fan R; Bian M; Hu L; Liu W
    Eur J Med Chem; 2019 Dec; 183():111721. PubMed ID: 31577978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondria-localizing dicarbohydrazide Ln complexes and their mechanism of in vitro anticancer activity.
    Meng T; Liu T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
    Dalton Trans; 2020 Apr; 49(14):4404-4415. PubMed ID: 32175553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure and biological properties of five Pt(II) complexes as potential anticancer agents.
    Deng J; Wang J; Khan M; Yu P; Yang F; Liang H
    J Inorg Biochem; 2018 Aug; 185():10-16. PubMed ID: 29730232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.